STOCK TITAN

Stryker Corp. - SYK STOCK NEWS

Welcome to our dedicated news page for Stryker (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Stryker's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Stryker's position in the market.

Rhea-AI Summary
Stryker introduces Triathlon Hinge and showcases Mako SmartRobotics at AAOS 2024, emphasizing innovation and commitment to surgical excellence. Triathlon Hinge offers versatility and simplicity in revision knee implant options, addressing challenges in complex cases. Mako aims to reduce intra-operative fluoroscopy in hip replacement, enhancing surgical accuracy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
none
-
Rhea-AI Summary
Stryker (SYK) has declared a quarterly dividend of $0.80 per share, representing a 6.7% increase from the prior year. The dividend is payable on April 30, 2024, to shareholders of record on March 29, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
dividends
-
Rhea-AI Summary
Stryker (SYK) to participate in Citi's 2024 Unplugged Medtech and Life Sciences Access Day, with company representatives presenting at Citigroup Headquarters in New York. The webcast of the presentation will be available on Stryker's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
conferences
Rhea-AI Summary
Stryker (SYK) launches Prophecy Footprint, expanding the Prophecy Surgical Planning system to offer comprehensive surgical planning across the entire foot. The system will be demonstrated at the American College of Foot and Ankle Surgeons Annual Meeting. Also, the company celebrates the tenth anniversary of the Infinity Total Ankle System, with a 98.8% survivorship at the two-year mark.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
none
-
Rhea-AI Summary
Stryker (NYSE:SYK) reported strong financial results for the fourth quarter and full year of 2023, with net sales increasing 11.8% to $5.8 billion in the quarter and 11.1% to $20.5 billion for the full year. Adjusted EPS increased 15.3% to $3.46 in the quarter and 13.5% to $10.60 for the full year. The company expects 2024 organic net sales growth to be in the range of 7.5% to 9.0% and adjusted net earnings per diluted share to be in the range of $11.70 to $12.00.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
earnings
-
Rhea-AI Summary
Stryker's Gamma4 Hip Fracture Nailing System has been used in over 19,000 cases since its launch in August 2022, across more than 850 facilities. The system has expanded with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components. It is indicated for the treatment of stable and unstable fractures, as well as for bone stabilization and correction of deformities in various regions of the femur. The press release emphasizes Stryker's commitment to providing innovative orthopaedic solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
Rhea-AI Summary
Stryker (SYK) announces successful completion of the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance, a new tool for surgeons to execute pre-operative plans with 3D imaging and operate with more precision and consistency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
none
-
Rhea-AI Summary
Stryker (SYK) achieved a historic milestone by surpassing $20 billion in annual sales for the first time in December 2023. Kevin Lobo, Chair and CEO, expressed excitement over this achievement, highlighting the positive impact on customers and patients. Stryker will provide further details on its 2023 financial performance during the Q4 and Full Year Earnings Call on January 30, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
none
-
Rhea-AI Summary
Stryker (NYSE:SYK) will report financial results for Q4 and full year 2023 on January 30, 2024. The press release will include summary financial information, and a webcast will be hosted to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
earnings
Rhea-AI Summary
Stryker (SYK) has executed a binding offer to acquire SERF SAS, a France-based joint replacement company known for its innovations in hip implants. The acquisition is expected to complement Stryker's global joint replacement portfolio and expand its presence in France and across Europe.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
acquisition
Stryker Corp.

NYSE:SYK

SYK Rankings

SYK Stock Data

134.03B
340.86M
6.47%
78.83%
1.1%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Portage

About SYK

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.